Editorial
What is “resistance” in Paget's disease of bone?
Kenneth W. Lyles MD,
Corresponding Author
Kenneth W. Lyles MD
Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, and Duke University Medical Center, Durham, North Carolina
Duke University Medical Center, Division of Geriatrics, Department of Medicine, 2507 Busse Building, Box 3881 DUMC, Durham, NC 27710Search for more papers by this authorKenneth W. Lyles MD,
Corresponding Author
Kenneth W. Lyles MD
Geriatric Research Education and Clinical Center, Veterans Affairs Medical Center, and Duke University Medical Center, Durham, North Carolina
Duke University Medical Center, Division of Geriatrics, Department of Medicine, 2507 Busse Building, Box 3881 DUMC, Durham, NC 27710Search for more papers by this author
REFERENCES
- 1 Joshua F, Epstein M, Major G. Bisphosphonate resistance in Paget's disease. Arthritis Rheum 2003; 48: 2321–3.
- 2
Delmas PD,
Meunier PJ.
The management of Paget's disease of bone.
N Engl J Med
1997;
334:
558–66.
10.1056/NEJM199702203360807 Google Scholar
- 3 Van Staa TP, Selby P, Leufkens HG, Lyles K, Sprafka JM, Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002; 17: 465–71.
- 4 Cundy T, McAnulty K, Wattie D, Gamble G, Rutland M, Ibbertson HK. Evidence for secular change in Paget's disease. Bone 1997; 20: 60–71.
- 5 Morales Piga AA, Bachiller-Corral FJ, Abraira V, Beltran J, Rapado A. Is clinical expression of Paget's disease of bone decreasing? Bone 2002; 30: 399–403.
- 6 Cooper C, Schafheutle K, Dennison E, Kellingray S, Guyer P, Barker D. The epidemiology of Paget's disease in Britain: is the prevalence decreasing? J Bone Miner Res 1999; 14: 192–7.
- 7 Reddy SV, Singer FR, Roodman GD. Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence. J Clin Endocrinol Metab 1995; 80: 2108–11.
- 8 Gordon MT, Anderson DC, Sharpe PT. Canine distemper virus localized in bone cells of patients with Paget's disease. Bone 1991; 12: 195–201.
- 9 Helfrich MJ, Hobson RP, Grabowski PS, Zurbriggen A, Cosby SL, Dickson GR, et al. A negative search for a paramyxoviral etiology of Paget's disease: molecular immunological and ultrastructural studies in UK patients. J Bone Miner Res 2000; 15: 2315–29.
- 10 Rima BK, Gasson U, Helfrich MH, Raston SH. The pro and con of measles virus in Paget's disease: con [letter]. J Bone Miner Res 2002; 17: 2290–2.
- 11 Friedrichs WE, Reddy SV, Singer FR, Roodman GD. The pro and con of measles virus in Paget's disease: pro [letter]. J Bone Miner Res 2002; 17: 2293.
- 12 Morales-Piga AA, Rey-Rey JS, Corres-Gonzalez J, Garcia-Sagredo JM, Lopez-Abente G. Frequency and characteristics of familial aggregation of Paget's disease of bone. J Bone Miner Res 1995; 10: 663–70.
- 13 Laurin N, Brown JP, Lemainque A, Duchesne A, Huot D, Lacourciere Y, et al. Paget's disease of bone mapping of two loci at 5q35-qter an 5q31. Am J Hum Genet 2001; 69: 528–43.
- 14 Kanis JA. Pathophysiology and treatment of Paget's disease of bone. 2nd ed. London: Martin Dunitz; 1998; p. 159–220.
- 15 Miller DP, Brown JP, Siris ES, Hoseyni MS, Axelrod DW, Bekker PJ. A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Am J Med 1999; 106: 513–20.
